Contact Us   |   Print Page   |   Sign In   |   Join
News and Press: Member Organization News

Detroit R&D to be featured on Discovery Channel

Thursday, November 10, 2016   (0 Comments)
Posted by: Kate Oesterle
Share |

Detroit R&D specializes in research and development of diagnostics for various diseases and tools to screen for environmental toxicants under support of National Institutes of Health (NIH) SBIR funding (~10M since 1998). Detroit R&D markets life-science-related products directly or through 23 worldwide distributors (visit www.detroitrandd.com).

 

Recently, the Detroit R&D BioTarget® sEH Hypertension diagnostic (14,15-DHET ELISA) was selected as an innovative technology to be featured on the Discovery Channel Innovations TV series hosted by Ed Begley, Jr.

 

The initial broadcast will be on Nov. 22nd 7:30 AM (EST and PST). 

 

Watch the video HERE.

 

The FDA-exempt BioTarget®  sEH diagnostic detects 14,15-DHET (sEH metabolite) in blood and urine as a biomarker for hypertension-related diseases including cardiovascular diseases, heart attack, stroke, kidney diseases, diabetes and severe asthma.

This targeted personalized approach will correct the “trial and error” approach currently used by physicians worldwide who prescribe 1-4 drugs from ~75 FDA approved hypertension drugs.  Detroit R&D’s BioTarget®  precision hypertension diagnostics will save enormous medical costs ($150B projected for 2015 in US, projected to double to $274B in 2030) and lives from side effects, especially for the uncontrolled resistant hypertensive patients (~50% of the treated in US).



Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal